Abbreviation:
EXPERT OPIN DRUG DIS
ISSN:
1746-0441
eISSN:
1746-045X
Category:
PHARMACOLOGY & PHARMACY - SCIE
WoS Core Citation Indexes:
SCIE - Science Citation Index Expanded
Journal Impact Factor (JIF):
6
5-year Impact Factor:
6.6
Best ranking:
PHARMACOLOGY & PHARMACY (Q1) ― Percentage rank: 91.8%
Open Access Support:
Hybrid and Open Access Support
Country:
ENGLAND
Status in WoS core:
Active
Publisher:
N/A
» In order to submit a manuscript to this journal, please read the guidelines for authors in the journal's homepage.

» For a more in-depth analysis of the journal, you should subscribe and check it out on Journal Citation Reports (JCR).

» If you need a journal template (Word or Latex), you can read this entry.

» Journals of ESCI (except for fields of Arts and Humanities) are now ranked by JIF as the same with journals of SCIE and SSCI in the release of JCR 2023 (in 2024). Journals of AHCI and ESCI of Arts and Humanities are not ranked.

» Open access (OA) journals are free for readers. To maintain the business model, publishers will account for publication fees from authors, but some funds may cover the fees, and OA journals may not charge any fees.
Expert Opinion on Drug Discovery - WoS Journal Info
Get Embeded Code
Save the journal to Dashboard
  Menu Home Category & Quartile Countries & Regions Blog My Dashboard Membership About WJI